Catheter Precision Files Definitive Proxy Statement

TL;DR

Catheter Precision (CATM) filed its proxy statement for the 2025 shareholder meeting. Vote on directors & auditors.

AI Summary

Catheter Precision, Inc. filed its definitive proxy statement on November 25, 2024, for its 2025 annual meeting of stockholders. The company, formerly known as Ra Medical Systems, Inc., is seeking shareholder approval for various matters, including the election of directors and the ratification of its independent registered public accounting firm. The filing details executive compensation and other corporate governance items relevant to the upcoming meeting.

Why It Matters

This filing provides shareholders with crucial information regarding corporate governance, director elections, and executive compensation, enabling them to make informed voting decisions at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine filing of a definitive proxy statement, which is standard for public companies and does not inherently indicate new risks.

Key Numbers

• 2025 — Fiscal Year End (The company's fiscal year ends on December 31st, and this proxy statement pertains to matters for the 2025 period.)

Key Players & Entities

• Catheter Precision, Inc. (company) — Registrant
• Ra Medical Systems, Inc. (company) — Former company name
• 2025 (date) — Fiscal year end and meeting year
• November 25, 2024 (date) — Filing date

FAQ

Key Financial Figures

• $0.0001 — our outstanding common stock, par value $0.0001 per share ("Common Stock"), upon the ex

Filing Documents

• rmed_def14a.htm (DEF 14A) — 529KB
• rmed_def14aimg17.jpg (GRAPHIC) — 7KB
• rmed_def14aimg18.jpg (GRAPHIC) — 5KB
• rmed_def14aimg19.jpg (GRAPHIC) — 5KB
• rmed_def14aimg20.jpg (GRAPHIC) — 3KB
• rmed_def14aimg21.jpg (GRAPHIC) — 2KB
• rmed_def14aimg22.jpg (GRAPHIC) — 3KB
• rmed_def14aimg23.jpg (GRAPHIC) — 18KB
• 0001654954-24-014876.txt ( ) — 590KB

From the Filing

DEF 14A 1 rmed_def14a.htm FORM DEF 14A rmed_def14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under 240.14a12 Catheter Precision, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 011. 1670 Highway 160 West, Suite 205 Fort Mill, SC 29708 (973) 691-2000 To our Stockholders: We are pleased to invite you to attend the special meeting of stockholders (the "Special Meeting") of Catheter Precision, Inc. (the "Company"), to be held on January 13, 2025 at 12:00 p.m. Eastern Standard Time, or at any adjournment or postponement thereof. At the Special Meeting, you will be asked to approve a number of proposals, as described below. You are invited to attend and vote your shares at the Special Meeting live via internet webcast so long as you register to attend the Special Meeting at web.viewproxy.com/VTAK/2025 by 11:59 p.m. Eastern Standard Time on January 12, 2025 (the "Registration Deadline"). Questions will need to be submitted prior to the Special Meeting. To submit questions, please visit web.viewproxy.com/VTAK/2025 . You will not be able to attend the Special Meeting in person . At this year's Special Meeting, our stockholders will be asked to: approve, in accordance with NYSE American Company Guide Section 713(a), the issuance of up to 10,695,962 shares of our outstanding common stock, par value $0.0001 per share ("Common Stock"), upon the exercise of our Series K Common Stock Purchase Warrants, with the right for such potential exercise to occur immediately following the date upon which our stockholders approve this proposal (the "Warrant Exercise Proposal" or "Proposal No. 1"); approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from thirty (30) million shares to sixty (60) million shares (the "Certificate Amendment Proposal" or "Proposal No. 2"); approve an additional 1.5 million shares of common stock for issuance pursuant to our 2023 Equity Incentive Plan (the "Equity Plan Amendment Proposal" or "Proposal No. 3"); ratify the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2025, (the "Auditor Ratification Proposal" or "Proposal No. 4"); and approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposals Nos. 1, 2, 3 and/or 4 (the "Adjournment Proposal" or "Proposal No. 5"). Details regarding how to attend the Special Meeting and the business to be conducted at the Special Meeting are more fully described in the accompanying notice of Special Meeting of stockholders and proxy statement. Your vote is important. Regardless of whether you plan to attend the Special Meeting, it is important that your shares be represented and voted at the Special Meeting, and we hope you will vote as soon as possible. You may vote by proxy via the Internet, by telephone, or by mail, according to the instructions on the enclosed proxy card or voting instruction card. Voting over the Internet or by telephone, by written proxy or voting instruction card will ensure your representation at the Special Meeting regardless of whether you attend the Special Meeting. Thank you for your ongoing support of, and continued interest in, Catheter Precision, Inc. Sincerely, David A. Jenkins Executive Chairman of the Board Fort Mill, South Carolina November 25, 2024 Important Notice Regarding the Availability of Proxy Materials for the Special Meeting to Be Held on January 13, 2025. A copy of this proxy statement is available at web.viewproxy.com/VTAK/2025 and is available from the SEC on its website at www.sec.gov. These materials are also available to any stockholder who wishes to receive a paper copy by calling 1-877-777-2857, by emailing requests@viewproxy.com or by submitting a request over the Internet at web.viewproxy.com/VTAK/2025. CATHETER PRECISION, INC. 1670 Highway 160 West, Suite 205 Fort Mill, SC 29708 (973) 691-2000 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS Time and Date 12:00 p.m. Eastern Standard Time, on January 13, 2025, or any adjournment or postponement thereof. Webcast Address web.viewproxy.com/VTAK/2025 Items of Business To approve, in accordance wi

View Full Filing

View this DEF 14A filing on SEC EDGAR